Nectero Medical Completes $19.5 Million Series C Financing

11 Sep, 2021

Nectero Medical Completes $19.5 Million Series C Financing
Photo by Paico Oficial on Unsplash

Nectero Medical Inc. announced the closing of its $19.5m Series C financing round.
Proceeds will support the companys in vivo and clinical trials to develop a potentially disruptive treatment platform that stabilizes smallto midsized aortic aneurysms by significantly reducing their growth rate.

Health Care Health Diagnostics Medical Device North America
Crunchbase icon

Content report

The following text will be sent to our editors: